Tocainide for drug-resistant ventricular arrhythmias: Efficacy, side effects, and lidocaine responsiveness for predicting tocainide success
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
1978 • 523 citations
Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.
1976 • 140 citations
Kinetics of the oral antiarrhythmie lidocaine congener, tocainide
1976 • 109 citations
Long-term tocainide therapy for ventricular arrhythmias.
1978 • 103 citations
Suppression of ventricular ectopic depolarizations by tocainide.
1977 • 96 citations
Antiarrhythmic effects of a lidocaine congener, tocainide, 2‐amino‐2',6'‐propionoxylidide, in man
1976 • 92 citations
Clinical electrophysiologic effects of tocainide.
1978 • 87 citations
Electrophysiologic properties of a new antiarrhythmic drug—Tocainide
1978 • 80 citations
Antiarrhythmic and circulatory effects of astra W36095
1974 • 65 citations
The hemodynamic effects of intravenous tocainide in patients with heart disease.
1978 • 63 citations
Response optimization of drug dosage: Antiarrhythmie studies with tocainide
1977 • 54 citations
Assessment of long-term antiarrhythmic therapy: Studies on the long-term efficacy and toxicity of tocainide
1979 • 53 citations
High-Pressure Liquid Chromatographic Analysis of Drugs in Biological Fluids II: Determination of an Antiarrhythmic Drug, Tocainide, as Its Dansyl Derivative Using a Fluorescence Detector
1977 • 34 citations
Effects of tocainide on ventricular fibrillation threshold
1978 • 28 citations
Cited By (0)
No citing papers found in database